Stefano Di Lullo tells us why Sorin chose France for its research program. Sorin is a leader in the development of medical technologies in the cardio-vascular field. During the past 10 years, they have invested more than 200 million euros in Research and Development. Their INTENSE project has been chosen to be one of the “Projets de l’avenir” within the French government.